Philips vs TSMC
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dutch health technology company with €17B revenue; MRI/CT imaging and patient monitoring managing massive sleep apnea device recall competing with Siemens Healthineers and GE HealthCare.
About
Philips is a Dutch multinational technology and health technology company that has transformed from a broad consumer electronics conglomerate into a focused health technology leader — producing diagnostic imaging systems (MRI, CT, ultrasound), patient monitoring, hospital informatics, personal health products (electric toothbrushes, shavers, sleep apnea devices), and health informatics solutions. Listed on the Amsterdam Stock Exchange (AEX: PHIA) and headquartered in Amsterdam, Philips generates approximately €17 billion ($18 billion) in annual revenue after divesting its lighting division (now Signify) and domestic appliances business.\n\nPhilips' health technology portfolio spans two segments: Diagnosis & Treatment (imaging systems, image-guided therapy, and ultrasound for hospitals) and Connected Care (patient monitoring, respiratory care, sleep therapy). The Diagnosis & Treatment segment provides MRI systems, CT scanners, and X-ray equipment to hospitals globally. The Connected Care segment includes Philips' DreamStation and other sleep apnea (CPAP/BiPAP) devices, home respiratory care, and hospital patient monitoring platforms.\n\nIn 2025, Philips is managing the severe consequences of a 2021 recall of approximately 5.5 million sleep apnea devices (Philips Respironics DreamStation and related models) due to concerns that degraded polyester foam could release harmful particles and gases — one of the largest medical device recalls in history. The recall has resulted in multi-billion dollar settlements, regulatory scrutiny, and significant reputation damage in the sleep therapy market, allowing competitors ResMed and Fisher & Paykel to gain share. Philips' 2025 strategy focuses on resolving recall liabilities, rebuilding the sleep therapy business, and investing in AI-powered diagnostic imaging to compete with Siemens Healthineers and GE HealthCare.
Hsinchu Taiwan global foundry leader (NYSE: TSM) at $87.1B FY2024 revenue (+34%); AI chip revenue 3x growth with N2 2nm production 2025 and Arizona/Japan expansion serving Apple/NVIDIA competing with Samsung Foundry.
About
Taiwan Semiconductor Manufacturing Company (TSMC) is a Hsinchu, Taiwan-headquartered pure-play semiconductor foundry — publicly traded on the New York Stock Exchange (NYSE: TSM) and Taiwan Stock Exchange (TWSE: 2330) at approximately $800+ billion market capitalization — operating as the world's largest contract chipmaker with 60%+ global foundry market share, manufacturing semiconductors for Apple, NVIDIA, AMD, Qualcomm, Broadcom, and 500+ other fabless chip design companies. In FY2024, TSMC generated $87.1 billion in revenue (+34% year-over-year) with AI-related chip revenue growing 3x annually, reflecting the GPU and custom AI accelerator demand from hyperscalers. In 2025, TSMC's 2-nanometer (N2) process technology entered volume production (the world's most advanced at-scale semiconductor manufacturing), while the Arizona Fab 21 Phase 1 (4nm/N4P) began production in late 2024 and the Kumamoto, Japan fab opened in 2024. CEO C.C. Wei. Founded 1987 by Morris Chang, who pioneered the pure-play foundry model that separated chip design from manufacturing.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.